BIO 2026: Cell and gene therapy sector must break the mold to thrive

Trending

• Uncategorized8 months ago

  Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion

• Endpoints News8 months ago

  Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation

• Uncategorized7 months ago

  Optical Pooled CRISPR Screen Reveals Regulators of NF-κB Dynamics in Human Cells

• Uncategorized6 months ago

  Relay’s PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study

• Uncategorized5 months ago

  Hybrid solid−liquid optics enable scalable, high-resolution light-sheet microscopy across diverse immersion media

• Fierce Biotech8 months ago

  Scientists turn pig semen extract into eye drops that kill cancer in mice